The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 26, 2019

Filed:

Nov. 29, 2012
Applicant:

The Wistar Institute of Anatomy and Biology, Philadelphia, PA (US);

Inventors:

Gerd G. Maul, Wynnewood, PA (US);

Dmitri G. Negorev, West Chester, PA (US);

Louise C. Showe, Media, PA (US);

Olga V. Vladimirova, Philadelphia, PA (US);

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/00 (2006.01); C12N 5/02 (2006.01); C12N 15/63 (2006.01); C07H 21/04 (2006.01); A61K 48/00 (2006.01); A61K 35/545 (2015.01); C12N 5/074 (2010.01); C12N 5/077 (2010.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
A61K 48/005 (2013.01); A61K 35/545 (2013.01); C12N 5/0696 (2013.01); C07H 21/04 (2013.01); C12N 5/0656 (2013.01); C12N 15/113 (2013.01); C12N 15/63 (2013.01); C12N 2501/998 (2013.01); C12N 2506/1307 (2013.01); C12N 2510/00 (2013.01); C12N 2510/04 (2013.01); C12N 2740/15041 (2013.01);
Abstract

Compositions and methods described herein include somatic cells that are competent for reprogramming and malignant transformation and are characterized by a reduction of the levels of Sp100 in the cells, cells having markers of pluripotent stem cells, and methods for preparing same. Methods for reversably regulating aging or reprogramming to pluripotency in a somatic cell involve modulating the expression of Sp100 therein. Methods and compositions for retarding the growth of or suppressing unwanted cell proliferation involve expressing, inducing expression of, or upregulating, Sp100 in a targeted cell that is undergoing unrestricted proliferation or replication or increasing exposure to Sp100 in the environment or microenvironment of the targeted cell. Also disclosed are methods for treating a proliferative disease or condition by increasing expression or levels of Sp100 in the targeted cell or its environment.


Find Patent Forward Citations

Loading…